葵花药业：全资子公司夫西地酸乳膏上市许可申请获受理

Core Viewpoint - The company has received a registration acceptance notice from the National Medical Products Administration for its subsidiary's drug, Fusidic Acid Cream, which is intended for treating skin infections caused by various bacteria [1] Group 1: Drug Registration - The drug is classified as a Class 4 chemical drug [1] - The approval process is lengthy and involves multiple steps, leading to uncertainty regarding the completion time and approval results [1] - The company will continue to advance the registration process and monitor the approval status, providing timely updates [1]